rhACE2

recombinant human angiotensin-converting enzyme 2 · Apeiron Biologics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rhACE2, covering 2021-08-02 to 2021-08-02. Get the full timeline:

Most recent: Clinical Trial Update: Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 [Phase 2]